Anzeige
Mehr »
Login
Donnerstag, 09.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Vor Neubewertung: Kupfer-Geheimtipp veröffentlich in dieser Sekunde sensationelle Bohrergebnisse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
23 Leser
Artikel bewerten:
(0)

Deinove: Deinove announces its participation in the European Smallcap Event

April 7&8, 2014, Paris - Pullman Tour Eiffel hotel, France

Montpellier, April 1, 2014 - Deinove (Alternext Paris: ALDEI), a cleantech company that designs and develops new standards for industrial processes based on the exploitation of Deinococcus bacteria, announces today that it will participate in the "European Smallcap Event", organized by CF&B Communication. This day will take place on April 7&8, in Paris, France.

During this event, Emmanuel Petiot, CEO of DEINOVE, will present the Company, its development strategy and its latest news, in one-to-one meetings.

DEINOVE is committed to meet on a regular basis with the financial community. Investors can also find updated information on the company's website (www.deinove.com (http://www.deinove.com/)) and contact the investor relations team by writing to coralie.martin@deinove.com (mailto:coralie.martin@deinove.com).

ABOUT DEINOVE

DEINOVE (Alternext Paris: ALDEI) is ushering in a new era of green chemistry by designing and developing new standards of production based on bacteria of untapped potential: the Deinococci. Taking advantage of the bacteria's unique genetic properties and unusual robustness, DEINOVE optimizes natural fermentation and metabolic capabilities of these bacterial "micro-factories" to produce high value-added products from non-food biomass. The Company's primary markets are 2nd-generation biofuels (DEINOL) and bio-based chemicals (DEINOCHEM). On these markets, the Company offers its technology to industrial partners globally.

. Listed on NYSE Alternext since April 2010, DEINOVE was founded by Dr. Philippe Pouletty, General Partner of TRUFFLE CAPITAL, and Pr. Miroslav Radman, of the Faculty of Medicine of Paris Descartes University. The company employs over 40 people in its new offices and laboratories located at the Biopôle Euromédecine, in Montpellier, France.

More information at www.deinove.com (http://www.deinove.com/)

Contacts
DEINOVE
Emmanuel Petiot
CEO
Tel.: +33 (0) 4 48 19 01 28
emmanuel.petiot@deinove.com (mailto:emmanuel.petiot@deinove.com)
    
    
Coralie Martin
Communication, Marketing and IR Manager  
Tel.: +33 (0) 4 48 19 01 60  
coralie.martin@deinove.com (mailto:coralie.martin@deinove.com)
ALIZE RP, Press relations
Caroline Carmagnol and Sayuli Nishioka
Tel.: +33 (0) 1 70 22 53 90 / +33 (0) 1 70 22 53 86
Mobile: +33 (0) 6 64 18 99 59
deinove@alizerp.com (mailto:deinove@alizerp.com)

 
 



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Deinove via Globenewswire

HUG#1773466
Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2014 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.